NCT02665637View on ClinicalTrials.gov

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

PHASE1CompletedINTERVENTIONAL

Enrollment

70

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Trastuzumab

Each patient may receive single dose by intravenous infusion

Trial Locations (1)

78744

PPD Phase I Clinic, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Celltrion

INDUSTRY